secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2023-05-17T23:59:59+00:00
Accession:  0001493152-23-017984
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem Biosciences announces 1-for-125 reverse stock split effective May 18
---------------------------------------------------------------------------

- Reverse split ratio 1-for-125; reduces outstanding shares from ~249M to ~1.99M as of May 17, 2023.
- New CUSIP 30048L302; trades under EVFMD for 20 business days, then reverts to EVFM.
- No fractional shares issued; cash in lieu at closing price on May 17, 2023.
- Proportional adjustments to exercise prices and shares of stock options, warrants, convertible notes.
- Approved by stockholders at special meeting March 15, 2023; Board set exact ratio.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000149315223017984/0001493152-23-017984-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000149315223017984/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-017984

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer